Yeh is nationally recognized for her research in pediatric cancer survivorship and decision science. Using decision analytic, simulation modeling, and economic evaluation methods, her research focuses on improving cancer control policy across the cancer continuums. Yeh develops novel approaches to incorporate the effects of early-life exposures on long-term health outcomes to understand how treatment-related risks for secondary cancers, cardiac events and other late effects impact long-term health and quality of life among survivors of childhood and adolescent cancer. Most recently, Yeh received a R01 grant from NCI to study the clinical outcomes and cost-effectiveness of risk-reducing medications to prevent secondary breast cancer among childhood cancer survivors. The project brings together collaborators from the Cancer Intervention and Surveillance Modeling Network (CISNET), Childhood Cancer Survivor Study (CCSS) and St. Jude Lifetime Cohort Study (SJLIFE).
In addition to her research, Yeh actively trains and mentors Harvard graduate students, postdoctoral fellows, and clinical fellows. She serves as a member of the Harvard Faculty of Arts and Science’s Standing Committee on Health Policy and is a mentor for T32 training programs, including the Harvard-wide Pediatric Health Services Research Fellowship Program and the Dana Farber/Harvard Cancer Center’s Training in Oncology Population Sciences (TOPS) program.
Learn more: Read more about Jennifer Yeh
Related news: Newborn Genetic Screening for Pediatric Cancer Risk
Related news: Breast Cancer Screening in Childhood Cancer Survivors